Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.
Waddington
Cs
C
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Andrews
N
N
Hoschler
K
K
Walker
Wt
W
Oeser
C
C
Reiner
A
A
John
T
T
Wilkins
S
S
Casey
M
M
Eccleston
Pe
P
Allen
Rj
R
Okike
I
I
Ladhani
S
S
Sheasby
E
E
Waight
P
P
Collinson
Ac
A
Heath
Pt
P
Finn
A
A
Faust
Sn
S
Snape
Md
M
Miller
E
E
Pollard
Aj
A